SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?

Background 21-hydroxylase-deficiency (21OHD) accounts for more than 95% of CAH cases. Serum 17-hydroxyprogesteron (17OHP) and androstenedione (A4) are traditional biomarkers for monitoring therapy. While generally there is good linear correlation between 17OHP and A4, physicians are likely to encoun...

Descripción completa

Detalles Bibliográficos
Autores principales: Jha, Smita, Turcu, Adina F, Sinaii, Ninet, Brookner, Brittany, Veeraraghavan, Padmasree, Mallappa, Ashwini, Auchus, Richard Joseph, Merke, Deborah P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207767/
http://dx.doi.org/10.1210/jendso/bvaa046.1756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207767/
http://dx.doi.org/10.1210/jendso/bvaa046.1756

Ejemplares similares